압타머사이언스

291650KOSDAQ자연과학 및 공학 연구개발업

68.5 / 100

Reference Date: 2026-04-13

Financial Score23.5 / 40

News Sentiment15.0 / 25

Momentum15.0 / 20

Disclosure15.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Surged 38.0% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

AptaMera Science is a biotech company spun off from POSTECH in 2011, specializing in the development of innovative therapeutics based on aptamer technology and offering CRO services for biopharmaceutical analysis. Utilizing its proprietary ApDC® platform, the company is advancing the development of targeted anti-cancer drugs for solid and hematologic malignancies, with key candidates like AST-201 and AST-202 in clinical trials, and expanded into CRO services in 2024.

Number of Employees

44people

Average Salary

54.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 120.074.0Point

PBR

2.72Industry Average 3.825.5Point

Lower than industry avg (good)

ROE

-32.13Industry Average -32.113.5Point

In line with industry avg

Debt Ratio

3.91Industry Average 7.525.0Point

Lower than industry avg (good)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲284.5% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲15.8% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -45.2% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 1Neutral 0Negative 0Average Sentiment Score 70

Positive
압타머사이언스, 美 코스트코가 찍은 펫푸드 기업 인수…실적 퀀텀 점.....
압타머사이언스가 미국 프리미엄 펫푸드 기업 츌립 인수를 통해 반려동물 헬스케어 시장에 진출하며 실적 퀀텀 점프를 기대하고 있습니다.

Detailed Momentum

52-week position8.0Point

Near 52w high (97%, uptrend)

Current 1,908Won52-week high 1,94152-week low 684

1-month return6.0Point

1m +37.96% (strong rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

8 totalPositive 4Neutral 4Negative 0

Neutral증권발행결과(자율공시)2026-04-09
Positive[기재정정]주요사항보고서(유상증자결정)2026-04-06
Positive[기재정정]주요사항보고서(유상증자결정)2026-04-01
Neutral[기재정정]주요사항보고서(타법인주식및출자증권양수결정)2026-04-01
Neutral주요사항보고서(타법인주식및출자증권양수결정)2026-03-25